ARVI prevention in patients with nonspecific lung diseases

Respiratory infections are the most common pathology among all age groups and unfortunately, in today's world, there are objective reasons for a steady increase in the prevalence of respiratory infections (environmental degradation, urbanization, growth of harmful habits, malnutrition, unjustif...

Full description

Bibliographic Details
Main Author: YA Gornostaeva
Format: Article
Language:Russian
Published: Remedium Group LLC 2014-12-01
Series:Медицинский совет
Subjects:
Online Access:https://www.med-sovet.pro/jour/article/view/592
id doaj-364e4a4463e2420fa7da5c649488619e
record_format Article
spelling doaj-364e4a4463e2420fa7da5c649488619e2021-07-28T13:29:17ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902014-12-010781110.21518/2079-701X-2014-7-8-11592ARVI prevention in patients with nonspecific lung diseasesYA Gornostaeva0Institute of Immunology, Federal Medical and Biological Agency of Russia, Department of Clinical Immunology and Allergology, Moscow State Medical Stomatological University named after A.I. EvdokimovRespiratory infections are the most common pathology among all age groups and unfortunately, in today's world, there are objective reasons for a steady increase in the prevalence of respiratory infections (environmental degradation, urbanization, growth of harmful habits, malnutrition, unjustified antibiotic use, etc.). Prevention of respiratory infections remains a challenge for clinical medicine.https://www.med-sovet.pro/jour/article/view/592респираторные инфекциииммуномодули-\рующая терапияиммунотропные препаратыrespiratory infectionsimmunomodulating therapyimmunotropic drugs
collection DOAJ
language Russian
format Article
sources DOAJ
author YA Gornostaeva
spellingShingle YA Gornostaeva
ARVI prevention in patients with nonspecific lung diseases
Медицинский совет
респираторные инфекции
иммуномодули-\рующая терапия
иммунотропные препараты
respiratory infections
immunomodulating therapy
immunotropic drugs
author_facet YA Gornostaeva
author_sort YA Gornostaeva
title ARVI prevention in patients with nonspecific lung diseases
title_short ARVI prevention in patients with nonspecific lung diseases
title_full ARVI prevention in patients with nonspecific lung diseases
title_fullStr ARVI prevention in patients with nonspecific lung diseases
title_full_unstemmed ARVI prevention in patients with nonspecific lung diseases
title_sort arvi prevention in patients with nonspecific lung diseases
publisher Remedium Group LLC
series Медицинский совет
issn 2079-701X
2658-5790
publishDate 2014-12-01
description Respiratory infections are the most common pathology among all age groups and unfortunately, in today's world, there are objective reasons for a steady increase in the prevalence of respiratory infections (environmental degradation, urbanization, growth of harmful habits, malnutrition, unjustified antibiotic use, etc.). Prevention of respiratory infections remains a challenge for clinical medicine.
topic респираторные инфекции
иммуномодули-\рующая терапия
иммунотропные препараты
respiratory infections
immunomodulating therapy
immunotropic drugs
url https://www.med-sovet.pro/jour/article/view/592
work_keys_str_mv AT yagornostaeva arvipreventioninpatientswithnonspecificlungdiseases
_version_ 1721274577409015808